Companies

Companies

featured image of Virtual Drug Discovery Firm Raises $35m in Seed Funding for Breakthrough Medicines

Virtual Drug Discovery Firm Raises $35m in Seed Funding for Breakthrough Medicines

BIOT

📢 Relation Therapeutics Ltd 💊 secures US$35m 💰 in seed financing! 🌱 Accelerating drug discovery for osteoporosis and more! 🧪🧬 biotech investment

featured image of Revolutionary Partnership: Gene Therapy for Hemophilia

Revolutionary Partnership: Gene Therapy for Hemophilia

BIOT

ReciBioPharm teams up with GeneVentiv to create a groundbreaking gene therapy for hemophilia treatment. 🧬🔝✅

featured image of Revolutionary Partnership Targets $80bn Obesity Treatment Market

Revolutionary Partnership Targets $80bn Obesity Treatment Market

BIOT

🗞️ British companies Arecor Therapeutics and TRx Biosciences partner to develop an oral GLP-1 receptor agonist for obesity treatment. 🍔🍟💊💰💡

featured image of Revolutionary Cell Shuttle: Transforming Cell Therapy Manufacturing

Revolutionary Cell Shuttle: Transforming Cell Therapy Manufacturing

BIOT

📢 Cellares unveils Cell Shuttle, a clinically-compliant cell therapy manufacturing platform to meet global patient demand and reduce costs. 💉🚀🔬🎯💪🌐

featured image of Agathos Launches Game-Changing rAAV Service: Ethical Cell Line Revolutionizes Biomanufacturing

Agathos Launches Game-Changing rAAV Service: Ethical Cell Line Revolutionizes Biomanufacturing

BIOT

🔍 Agathos Biologics launches rAAV production service using AE1-BHK cell line, records first sale to Genovac. 💡✅🔬🌐

featured image of Polyplus Boosts GMP Protein Production in Belgium

Polyplus Boosts GMP Protein Production in Belgium

BIOT

🔍 Polyplus, part of Sartorius, expands GMP protein production and adds capacity in Belgium. Exciting news for Xpress Biologics! 🚀

featured image of Revolutionizing Therapy Development with ExoXpert: Harnessing the Power of Exosomes

Revolutionizing Therapy Development with ExoXpert: Harnessing the Power of Exosomes

BIOT

🌟 Introducing ExoXpert: A game-changing contract development and manufacturing organization for exosome-based therapies! 🚀 ExosomeTherapies CuttingEdgeTech

featured image of SynaptixBio Receives FDA ODD for Leukodystrophy Treatment

SynaptixBio Receives FDA ODD for Leukodystrophy Treatment

BIOT

📰 Rare disease specialist SynaptixBio Ltd receives FDA ODD for TUBB4A leukodystrophy, allowing research on therapy for isolated hypomyelination. 💊💡✨

featured image of Moderna Teams Up for Biotech Breakthroughs and Rare Diseases

Moderna Teams Up for Biotech Breakthroughs and Rare Diseases

BIOT

🌱 Moderna teams up with Form Bio and Ginkgo Bioworks to advance biotechnology roots, focusing on mRNA therapeutics and vaccines. 🧬🌍 Researchers also prioritize rare autoimmune diseases for better patient outcomes.

featured image of Revolutionary PulseSight: Game-changing Treatment for AMD

Revolutionary PulseSight: Game-changing Treatment for AMD

BIOT

📢 PulseSight Therapeutics aims to disrupt AMD space with innovative gene therapy and minimally-invasive delivery technology.💉💊✅